Palisade Bio (PALI) Short term Debt (2013 - 2025)
Palisade Bio's (PALI) quarterly Short term Debt came in at $235000.0 in Q3 2025, up 256.06% on a QoQ basis from $66000.0 in Q2 2025.
Palisade Bio (PALI) Short term Debt (2013 - 2025) Analysis & Trends
Palisade Bio (PALI) has 10 years of Short term Debt data on file, last reported at $235000.0 in Q3 2025.
- On a quarterly basis, Short term Debt changed N/A year-over-year to $235000.0 in Q3 2025; TTM through Sep 2025 was $235000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $143000.0, changed N/A from the prior year.
- Short term Debt for Q3 2025 stood at $235000.0, up from $66000.0 in the prior quarter.
- Over the last five years, Short term Debt for PALI reached as high as $1.1 million in Q2 2021 and fell as low as $66000.0 in Q2 2025.
- Historically, Short term Debt has averaged $254125.0 across 4 years, with a median of $143000.0 in 2023.
- Across the five-year window, Short term Debt tumbled 91.69% in 2021 and sank 51.75% in 2025, its largest moves.
- Year by year, Short term Debt stood at $87000.0 in 2021, then soared by 64.37% to $143000.0 in 2023, then climbed by 4.2% to $149000.0 in 2024, then jumped by 57.72% to $235000.0 in 2025.
- Per Business Quant data, the three most recent Short term Debt figures were $235000.0 in Q3 2025, $66000.0 in Q2 2025, and $69000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 235,000.00 |
| Jun 30, 2025 | 66,000.00 |
| Mar 31, 2025 | 69,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Mar 31, 2024 | 143,000.00 |
| Dec 31, 2023 | 143,000.00 |
| Dec 31, 2021 | 87,000.00 |
| Jun 30, 2021 | 1.14 Mn |
| Dec 31, 2020 | 1.05 Mn |
| Mar 31, 2017 | 2.53 Mn |
| Dec 31, 2016 | 3.71 Mn |
| Sep 30, 2016 | 4.83 Mn |
| Jun 30, 2016 | 5.91 Mn |
| Mar 31, 2016 | 4.47 Mn |
| Dec 31, 2015 | 4.55 Mn |
| Sep 30, 2015 | 4.46 Mn |
| Jun 30, 2015 | 3.17 Mn |
| Mar 31, 2015 | 1.93 Mn |
| Dec 31, 2014 | 730,012.00 |
| Sep 30, 2014 | 3.06 Mn |